Bio Insight
Advancing NAD Biomarkers From Research Discovery To Clinical Reality
As interest in metabolic health, longevity science, and precision medicine continues to grow, the ability to accurately measure biological markers linked t...
June 02, 2026 | Interview
Innovation Powerhouse or Inflated Bubble? Reading China’s First-in-Class Boom
A decade ago, the phrase “Chinese first-in-class drug” would have drawn a raised eyebrow in any Western boardroom. China made generics, copied ...
June 02, 2026 | Analysis | By arcilla.fran@biopharmaapac.com
When America Builds a Wall: Who Inherits China’s Displaced Biotech Work?
When President Trump signed the FY2026 National Defense Authorization Act on December 18, 2025, the biopharmaceutical industry finally got the law it had s...
June 02, 2026 | Analysis | By arcilla.fran@biopharmaapac.com
Daiichi Sankyo Targets Global Top Five Oncology Position By 2035
2.3 trillion yen in oncology revenue to be delivered by 2030 through the launch of 20 new indications across five medicines Identifying breakthrough g...
May 12, 2026 | News
Engineering Precision In Chromatography From Development To Commercial Scale
Chromatography in Bioprocessing For pilot and commercial purification of monoclonal antibodies and recombinant proteins, chromatography remains the centra...
April 24, 2026 | Analysis
Can AI close the MSK inequality gap? Improving access to musculoskeletal care in the UK
Behind these statistics lies a deeper and more troubling social divide: that the greatest burden is carried by those in our most deprived communities and m...
April 14, 2026 | Opinion | By Peter Grinbergs, Chief Medical Officer and Co‑founder of EQL
NCIS Leads Multidisciplinary Push To Transform Sarcoma Diagnosis And Care In Singapore
NCIS leads multi-institutional effort to develop expert multidisciplinary guidance to improve sarcoma diagnosis, referrals and outcomes Singapore is stren...
April 13, 2026 | News
From Staging to Survival: How AI-Driven Histological Analysis Is Solving Colorectal Cancer's Overtreatment Problem
The hidden cost of getting treatment decisions wrong Colorectal cancer (CRC) is one of the most prevalent and lethal cancers worldwide, ranking among the ...
April 02, 2026 | Expert Insight | By Dr. Torbjørn Furuseth, CEO and Co-Founder, DoMore Diagnostics
Taiwan Strengthens Its Position In Asia’s Next Phase Of Bioprocessing Growth
Taiwan’s bioprocessing and biotechnology sector has moved from a predominantly research-and-services footing toward a more industrialised, globally c...
March 20, 2026 | Analysis
From Concept to Validation-Ready: How Nelipak’s Singapore Hub Aims to Accelerate APAC Healthcare Packaging to Global Scale
Nelipak Healthcare Packaging has launched a new Asia-Pacific Technical Development Center in Singapore, establishing an integrated hub that unites ...
March 17, 2026 | Interaction
Turning Frontline Reality Into Policy Action For Cancer Care In Asia
Drawing on her frontline clinical experience in Malaysia, Prof Dr Wan Zamaniah, Consultant Clinical Oncologist, University Malaya Medical Centre&...
February 02, 2026 | Expert Insight
Closing Asia’s Cancer Evidence Gap Through Translational Science And Policy Leadership
In this BioPharma APAC interview, Dr Yun Yen, Program Committee Chair for the 2026 ASCO Breakthrough meeting, shares a candid translational...
February 02, 2026 | Expert Insight
China Originated Innovation Is Rising. Global Expectations Are Rising Even Faster.
The momentum is real—and so is the level of scrutiny. As more programs move beyond regional boundaries, expectations from global biopharma companies ...
February 02, 2026 | News | By Anil Kane, executive director, global head of technical and scientific affairs, Thermo Fisher Scientific
From Capacity to Capability: How 2026 can be the catalyst for what APAC’s Biopharma Growth Needs Next
Beyond Scale: What Will Sustain APAC’s Biopharma Leadership Asia-Pacific’s rise in global biopharma is no longer about whether the region can ...
January 21, 2026 | News | By Joonho Choi, Vice President, Asia-Pacific, Cytiva
Most Read
- How Does GLP-1 Work?
- Innovations In Magnetic Resonance Imaging Introduced By United Imaging
- Management of Relapsed/Refractory Multiple Myeloma
- 2025 Drug Approvals, Decoded: What Every Biopharma Leader Needs to Know
- BioPharma Manufacturing Resilience: Lessons From Capacity Expansion and Supply Chain Resets from 2025
- APAC Biopharma Review 2025: Innovation, Investment, and Influence on the Global Stage
- Top 25 Biotech Innovations Redefining Health And Planet In 2025
- The New AI Gold Rush: Western Pharma’s Billion-Dollar Bet on Chinese Biotech
- Single-Use Systems Are Rewiring Biopharma Manufacturing
- The State of Biotech and Life Science Jobs in Asia Pacific – 2025
- Asia-Pacific Leads the Charge: Latest Global BioSupplier Technologies of 2025
- Invisible Threats, Visible Risks: How the Nitrosamine Crisis Reshaped Asia’s Pharmaceutical Quality Landscape
Bio Jobs
- Sanofi Turns The Page As Belén Garijo Steps In And Paul Hudson Steps Out
- Global Survey Reveals Nearly 40% of Employees Facing Fertility Challenges Consider Leaving Their Jobs
- BioMed X and AbbVie Begin Global Search for Bold Neuroscience Talent To Decode the Biology of Anhedonia
- Thermo Fisher Expands Bengaluru R&D Centre to Advance Antibody Innovation and Strengthen India’s Life Sciences Ecosystem
- Accord Plasma (Intas Group) Acquires Prothya Biosolutions to Expand Global Plasma Capabilities
- ACG Announces $200 Million Investment to Establish First U.S. Capsule Manufacturing Facility in Atlanta
- AstraZeneca Invests $4.5 Billion to Build Advanced Manufacturing Facility in Virginia, Expanding U.S. Medicine Production
News
Editor Picks
